Assenagon Asset Management S.A. Spero Therapeutics, Inc. Transaction History

Assenagon Asset Management S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	BUY	$0.74 - $7.44 $79,843 - $802,753	107,897 Added 466.62%	131,020 $97,000
Q1 2022 Apr 25, 2022	BUY	$7.87 - $15.15 $181,978 - $350,313	23,123 New	23,123 $201,000
Q2 2021 Jul 15, 2021	SELL	$12.22 - $15.79 $2.22 Million - $2.87 Million	-181,578 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$13.23 - $21.48 $764,601 - $1.24 Million	57,793 Added 46.69%	181,578 $2.67 Million
Q4 2020 Feb 01, 2021	BUY	$11.65 - $22.07 $1.44 Million - $2.73 Million	123,785 New	123,785 $2.4 Million

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $41.4M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.